To further validate the efficacy of DASA+ATO@PLT in remodeling the tumor microenvironment in vivo, changes in the inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), within the tumor were examined. This evidence concerns the gene IL6 and neoplasm.